Although fetal development restriction was not captured as a specific indication for cesarean delivery, our outcomes remained unchanged following the exclusion of possibly growth-restricted neonates . It is possible that some earlier term deliveries may have been performed due to maternal perception of decreased fetal movement . Although such patients should generally go through antepartum fetal examining for indications suggesting fetal compromise20 , clinicians may forgo fetal screening before delivery in term. This might have affected our outcomes in the unlikely event that even more of such deliveries occurred before than after 39 weeks. Important is the accuracy with which we assigned gestational age Also. Our results were materially unchanged in analyses restricted to infants with gestational age estimated by first – or second-trimester ultrasound exam, instead of by third-trimester ultrasound examination or last menstrual period only.The UK Clinical Trials Database covers cell therapy clinical trial activity that the Cell Therapy Catapult believes to be ongoing in the UK as of April 2015. It’s been verified and compiled by the Cell Therapy Catapult group, and contains: Related StoriesSome antibiotics could make MRSA more harmfulLiposomal sizing and the Coulter principle: an interview with Professor Melvin E. KlegermanProtein sensor for proprioception found commercial and academic trials authorized for inclusion by the sponsor ongoing trials in the UK, whatever the nationality of the sponsor all trials including cells as therapeutic agents* The database is of use to academics, experts and commercial organisations operating in neuro-scientific cell therapy by permitting them to understand the extent of activity in the UK.